4.7 Article

Cap-assisted EMR of large, sporadic, nonampullary duodenal polyps

期刊

GASTROINTESTINAL ENDOSCOPY
卷 76, 期 6, 页码 1160-1169

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.gie.2012.08.009

关键词

-

向作者/读者索取更多资源

Background: EMR is an effective alternative to surgery for the removal of nonampullary duodenal polyps (NADPs). Cap-assisted EMR (EMR-C) has been rarely performed in the duodenum because of the risk of perforation. Objective: To evaluate the safety and effectiveness of EMR-C for the removal of large (>= 15 mm) NADPs. Design: Retrospective study. Setting: Tertiary-care referral center. Patients: Between 2000 and 2010, 26 consecutive patients with sporadic NADPs underwent EMR-C. Intervention: EMR with the cap technique. Main Outcome Measurements: Complete eradication of polyps, complications, and recurrence. Results: A total of 14 sessile polyps (53.8%), 7 lateral spreading type nongranular tumors (26.9%), and 5 lateral spreading type granular tumors (19.2%) were treated. The median size of lesions was 15 mm. Five lesions involved one-half of the luminal circumference. Post-EMR histologic assessment showed low-grade dysplasia in 5 patients (19.2%) and high-grade dysplasia in 18 patients (69.2%). Three patients (11.5%) had well-differentiated endocrine tumors. Complete eradication was obtained in 25 of 26 (96%) patients. No perforations occurred. Three cases of intraprocedural bleeding were managed endoscopically. Median follow-up was 6 years (range 1-10 years). Residual adenomatous tissue was observed in 3 patients in lesions of 50 mm. In one of these cases, an adenocarcinoma occurred after 8 months, which was managed surgically. Limitations: Retrospective design, single center. Conclusion: This study supports the efficacy and safety of EMR-C for removing NADPs. Regular follow-up is mandatory because of the high risk of residual or recurrent adenomatous tissue and even cancer. (Gastrointest Endosc 2012;76:1160-9.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据